📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years. (2018)

First Author: Muller I

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/thy.2018.0232

PubMed Identifier: 30351224

Publication URI: http://europepmc.org/abstract/MED/30351224

Type: Journal Article/Review

Volume: 28

Parent Publication: Thyroid : official journal of the American Thyroid Association

Issue: 12

ISSN: 1050-7256